UnitedHealth Group Incorporated (NYSE:UNH) Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total value of $96,440.71. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.23 on Friday, hitting $209.90. The company’s stock had a trading volume of 1,881,773 shares, compared to its average volume of 3,109,878. The firm has a market capitalization of $204,130.00, a PE ratio of 22.05, a PEG ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $148.56 and a 12 month high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.17 earnings per share. analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 34.09%.
Several institutional investors and hedge funds have recently modified their holdings of UNH. Capital International Investors increased its position in shares of UnitedHealth Group by 399.3% during the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock worth $809,370,000 after acquiring an additional 3,304,902 shares during the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 146.0% during the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock worth $1,085,396,000 after acquiring an additional 3,289,470 shares during the last quarter. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% during the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock worth $13,573,000 after acquiring an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of UnitedHealth Group by 1,820.1% during the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after acquiring an additional 2,264,242 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the last quarter. Institutional investors own 86.00% of the company’s stock.
UNH has been the subject of several recent research reports. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Morgan Stanley raised their price objective on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Leerink Swann restated a “buy” rating and set a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $216.65.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.